Skip to search boxSkip to navigationSkip to main content

APC dysfunction is correlated with defective suppression of T cell proliferation in human type 1 diabetes

  • Yulan Jin
    ,
  • Xueqin Chen
    ,
  • Robert Podolsky
    ,
  • Diane Hopkins
    ,
  • Levi H.C. Makala
    ,
  • Andy Muir
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

<p>It is widely believed that CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells (Treg) are defective in type 1 diabetes (T1D) and other autoimmune diseases. However, this conclusion is based on the suboptimal in vitro suppression results from very small numbers of subjects. Furthermore, the cells responsible for the suboptimal suppression have not been defined. Therefore, we carried out extensive in vitro suppression assays using both autologous and heterologous donors of Tregs, effector T cells and antigen-presenting cells (APC) from both T1D patients and normal controls. Our in vitro suppression data indicated that a significantly higher proportion (40.0%) of T1D patients have "very low suppression" activity (defined as < 25%) by autologous Treg compared to controls (6.3%) (p = 0.002). Meta-analysis of the published results confirmed this observation with 45.7% low suppressors in T1D and 7.8% in controls (p = 0.00002). Interestingly, suppression assays using heterologous Tregs, effector T cells and APC suggest that the source of APC is correlated with the suppression activity. The frequencies of CD4<sup>+</sup>CD25<sup>+</sup> and CD4<sup>+</sup>CD25<sup>hi</sup> T cells were found to increase with age in normal controls but not in T1D patients, resulting in significantly higher frequencies of CD4<sup>+</sup>CD25<sup>+</sup> (p = 0.001) and CD4<sup>+</sup>CD25<sup>hi</sup> (p = 0.009) T cells in young T1D subjects than age-matched controls but slightly lower CD4<sup>+</sup>CD25<sup>+</sup> (p = 0.003) and CD4<sup>+</sup>CD25<sup>hi</sup> (p = 0.08) T cells in old T1D subjects than age-matched controls.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 272-279 (8 pages)

Journal (Volume, Issue Number)

Clinical Immunology (Volume 130, Issue 3)

Publication milestones

  • Published - 03/2009

Publication status

Published - 03/2009

ISSN

1521-6616

Publication IDs

  • Scopus: 59249097729
  • PubMed: 19036642

Publication metrics

Metrics

SciVal
FWCI
0.40
SciVal
Author count
7
SciVal
citations
22
SciVal
Paper percentile
76
Fractional count
3
Fractional count
0.43
Fractional count
4
Fractional count
0.57
Fractional count
3
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Captures
26
Citation count
23

Funding Details

This work was partially supported by grants from the National Institutes of health (2RO1HD37800, 4R33DK069878, 4R33HD050196 and 5U24DK58778) and Juvenile Diabetes Research Foundation International (JDRF 1-2004-661) to JXS.
FundersFunding numbers
JDRF
-
NICHD
-
NIH
-
NIDDK
R33DK069878, UC4DK063865, U24DK058778
JDRF
1-2004-661
NICHD
R21HD050196, R01HD037800